Triple-drug therapy for post-transplant management of multiple myeloma

by University of Chicago Medical CenterCredit: Unsplash/CC0 Public DomainResearchers from the University of Chicago Medicine Comprehensive Cancer Center and colleagues in Poland report promising

Updated on: February 18,2024

Triple-drug therapy for post-transplant management of multiple myeloma

by University of Chicago Medical CenterCredit: Unsplash/CC0 Public DomainResearchers from the University of Chicago Medicine Comprehensive Cancer Center and colleagues in Poland report promising

Updated on:February 18,2024

ASCO: undertreatment seen for women with head and neck cancer

(HealthDay)—Females with head and neck cancer (HNC) are less likely to receive intensive chemotherapy and radiation, and have an increased relative risk for death from HNC versus other causes, accordi

Updated on: March 30,2024

ASCO: undertreatment seen for women with head and neck cancer

(HealthDay)—Females with head and neck cancer (HNC) are less likely to receive intensive chemotherapy and radiation, and have an increased relative risk for death from HNC versus other causes, accordi

Updated on:March 30,2024

Predicting oral cancer-related mortality among adults using machine learning approach

by International Association for Dental, Oral, and Craniofacial ResearchCredit: Unsplash/CC0 Public DomainA study aiming to predict oral cancer-related mortality among adults in the United States and

Updated on: March 30,2024

Predicting oral cancer-related mortality among adults using machine learning approach

by International Association for Dental, Oral, and Craniofacial ResearchCredit: Unsplash/CC0 Public DomainA study aiming to predict oral cancer-related mortality among adults in the United States and

Updated on:March 30,2024

New research results explore the safety of short-term cultivated CAR T cells in cancer immunotherapy

by Susanne Stöcker, Paul-Ehrlich-Institut - Bundesinstitut für Impfstoffe und biomedizinische ArzneimittelTo make CAR T cells available to all patients, various strategies facilitating the manufacturi

Updated on: March 30,2024

New research results explore the safety of short-term cultivated CAR T cells in cancer immunotherapy

by Susanne Stöcker, Paul-Ehrlich-Institut - Bundesinstitut für Impfstoffe und biomedizinische ArzneimittelTo make CAR T cells available to all patients, various strategies facilitating the manufacturi

Updated on:March 30,2024

Evidence supports three-year interval for multi-target stool DNA screening for those at average risk of colon cancer

by Regenstrief InstituteCredit: Unsplash/CC0 Public DomainA scientific study exploring the appropriate interval for colorectal cancer screening via non-invasive multi-target stool DNA testing for

Updated on: February 03,2024

Evidence supports three-year interval for multi-target stool DNA screening for those at average risk of colon cancer

by Regenstrief InstituteCredit: Unsplash/CC0 Public DomainA scientific study exploring the appropriate interval for colorectal cancer screening via non-invasive multi-target stool DNA testing for

Updated on:February 03,2024

Self-reported screening can reduce distressing symptoms for pediatric patients with cancer

byUniversity of TorontoCredit: Unsplash/CC0 Public DomainRegular, self-reported symptom screening was associated with reduced symptom burden when compared with usual care for pediatric patients

Updated on: December 01,2024

Self-reported screening can reduce distressing symptoms for pediatric patients with cancer

byUniversity of TorontoCredit: Unsplash/CC0 Public DomainRegular, self-reported symptom screening was associated with reduced symptom burden when compared with usual care for pediatric patients

Updated on:December 01,2024

New imaging technique accurately detects aggressive kidney cancer

by Denise Heady,University of California, Los AngelesRepresentative imaging with [89Zr]Zr-girentuximab. Credit:The Lancet Oncology(2024). DOI: 10.1016/S1470-2045(24)00402-9A new stud

Updated on: November 10,2024

New imaging technique accurately detects aggressive kidney cancer

by Denise Heady,University of California, Los AngelesRepresentative imaging with [89Zr]Zr-girentuximab. Credit:The Lancet Oncology(2024). DOI: 10.1016/S1470-2045(24)00402-9A new stud

Updated on:November 10,2024

Prostate cancer 'test by request' policies drive overdiagnosis and inequity with minimal benefit, argue experts

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainMost high income countries, including the U.K., do not have a national prostate cancer screening program, but instead allow men without

Updated on: January 21,2024

Prostate cancer 'test by request' policies drive overdiagnosis and inequity with minimal benefit, argue experts

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainMost high income countries, including the U.K., do not have a national prostate cancer screening program, but instead allow men without

Updated on:January 21,2024

Novel immunotherapy agent safe, shows promise against high-risk prostate cancers

byJohns Hopkins University School of MedicinePatient consort diagram and efficacy outcomes in the neoadjuvant treatment of patients with PCa using enoblituzumab. Credit:Nature Medicine&nbs

Updated on: January 15,2024

Novel immunotherapy agent safe, shows promise against high-risk prostate cancers

byJohns Hopkins University School of MedicinePatient consort diagram and efficacy outcomes in the neoadjuvant treatment of patients with PCa using enoblituzumab. Credit:Nature Medicine&nbs

Updated on:January 15,2024

Redefining colorectal cancer subtypes

by The City University of New YorkCredit: The City University of New YorkThere is a long-standing belief that colorectal cancer (CRC), which causes some 50,000 deaths in the United States each ye

Updated on: April 07,2024

Redefining colorectal cancer subtypes

by The City University of New YorkCredit: The City University of New YorkThere is a long-standing belief that colorectal cancer (CRC), which causes some 50,000 deaths in the United States each ye

Updated on:April 07,2024

Potential way to treat and prevent cancer in children with neuroblastoma

by Aminex Therapeutics, Inc.Photos of Professor Michelle Haber AM Executive Director of Children's Cancer Institute Australia Credit: Children’s Cancer Institute AustraliaThe MYCN oncogene has lon

Updated on: April 10,2024

Potential way to treat and prevent cancer in children with neuroblastoma

by Aminex Therapeutics, Inc.Photos of Professor Michelle Haber AM Executive Director of Children's Cancer Institute Australia Credit: Children’s Cancer Institute AustraliaThe MYCN oncogene has lon

Updated on:April 10,2024

New way to target cancer's diversity and evolution

by Institute of Cancer ResearchCredit: CC0 Public DomainScientists have revealed close-up details of a vital molecule involved in the mix and match of genetic information within cells—opening up

Updated on: April 14,2024

New way to target cancer's diversity and evolution

by Institute of Cancer ResearchCredit: CC0 Public DomainScientists have revealed close-up details of a vital molecule involved in the mix and match of genetic information within cells—opening up

Updated on:April 14,2024